National Research's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2022 was $4.3 Mil. National Research's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2022 was $21.2 Mil. National Research's Total Stockholders Equity for the quarter that ended in Mar. 2022 was $81.5 Mil.
National Research's debt to equity for the quarter that ended in Mar. 2022 was 0.31.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for National Research's Debt-to-Equity or its related term are showing as below:
NRC'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0 Med: 0.18 Max: 1.98
Current: 0.31
During the past 13 years, the highest Debt-to-Equity Ratio of National Research was 1.98. The lowest was 0.00. And the median was 0.18.
National Research Debt-to-Equity Historical Data
The historical data trend for National Research's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
|
National Research Annual Data
|
|
Trend |
Dec12 |
Dec13 |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
| Debt-to-Equity |
|
|
|
|
|
|
0.01 |
1.98 |
1.04 |
0.48 |
0.31 |
|
National Research Quarterly Data
|
|
Jun17 |
Sep17 |
Dec17 |
Mar18 |
Jun18 |
Sep18 |
Dec18 |
Mar19 |
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
| Debt-to-Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.40 |
0.38 |
0.33 |
0.31 |
0.31 |
Competitive Comparison
For the Health Information Services subindustry, National Research's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
National Research Debt-to-Equity Distribution
For the Healthcare Providers & Services industry and Healthcare sector, National Research's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where National Research's Debt-to-Equity falls into.
National Research Debt-to-Equity Calculation
Debt to Equity measures the financial leverage a company has.
National Research's Debt to Equity Ratio for the fiscal year that ended in Dec. 2021 is calculated as
National Research's Debt to Equity Ratio for the quarter that ended in Mar. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
National Research Business Description
Traded in Other Exchanges
Address
1245 Q Street, Lincoln, NE, USA, 68508
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. The solutions are offered at an enterprise level through the Voice of the Customer platform, The Governance Institute, and legacy Experience solutions. It operates in the US and Canada, of which key revenue is derived from the US.
Executives
| Jackson Steven D. |
officer: President |
C/O NATIONAL RESEARCH CORPORATION 1245 Q STREET LINCOLN NE 68508 |
| Martin Joann M |
director |
6221 ANDREW COURT LINCOLN NE 68512 |
| Nunnelly John N |
director |
P.O. BOX 2175 AMHERST MA 01004 |
| Karas Kevin R |
officer: SVP Finance, CFO, Treas & Secy |
C/O NATIONAL RESEARCH CORPORATION 1245 Q STREET LINCOLN NE 68508 |
| Berwick Donald M |
director |
C/O NATIONAL RESEARCH CORPORATION 1245 Q STREET LINCOLN NE 68508 |
| Mowry Barbara |
director |
P.O. BOX 103115 DENVER CO 80250 |
| Amandla Mk Trust |
10 percent owner |
C/O THE BRYN MAWR TRUST COMPANY OF DELAW 20 MONTCHANIN RD, SUITE 100 GREENVILLE DE 19807 |
| Hays Michael D. |
director, officer: CEO |
C/O NATIONAL RESEARCH CORPORATION 1245 Q STREET LINCOLN NE 68508 |
| K/i/e Trust Under Agreement 10/24/18 |
10 percent owner |
C/O BESSEMER TRUST COMPANY OF DELAWARE 1007 N. ORANGE ST., SUITE 1450 WILMINGTON DE 19801 |
| Endacott Kent E. |
10 percent owner |
C/O WOODS & AITKEN LLP 301 SOUTH 13TH STREET, SUITE 500 LINCOLN NE 68508 |
| Beans Patrick E |
director, officer: CFO and Secretary |
AMANDLA LLC 709 PIER 2 LINCOLN NE 68528 |
| Warden Gail L |
director |
250 WASHINGTON RD GROSSE POINTE MI 48230 |
| Henricks Susan L |
officer: President and COO |
C/O NATIONAL RESEARCH CORPORATION 1245 Q STREET LINCOLN NE 68508 |
| Schorr Paul C Iii |
director |
PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: SCHORR PAUL C III a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;} |
| Peetz Jeffery T |
10 percent owner |
WOODS & AITKEN LLP 301 SOUTH 13TH STREET, SUITE 500 LINCOLN NE 68508 |
National Research Headlines
By Seekingalpha 2020-05-09
By Seekingalpha 2022-02-09
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
0.51(1.55%) Volume: 30,232 4:00PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NAS:NRC has been successfully added to your 